NIH: NCI Director speaks on eliminating cancer by 2015:

[mhutch1366]

A collaboration between government, industry, and research to look at the biotechnology available, and the mission of NCI over the next decade. Available on video cast ( I believe).

""On March 19, the Director of the National Cancer Institute (NCI), Dr. Andrew von Eschenbach will introduce the second speaker in a new lecture series, the “NCI Director’s Seminar Series“. Carl Feldbaum, president of the Biotechnology Industry Organization (BIO) will give a talk entitled “Biotechnology and NCI: Partners in Bringing Patients the Next Generation of Cancer Therapy.” As with other speakers in this series, Carl Feldbaum is a nationally known leader involved in work that directly impacts the NCI’s challenge goal to eliminate the suffering and death due to cancer by 2015. BIO, the organization he heads, represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 states and 33 nations.

This is an exciting and innovative time for the biotechnology industry and for medical research, a time when collaboration can yield astounding results. Carl Feldbaum will give an overview of the biotechnology industry including what it has accomplished in cancer therapies, how it works, and how it is financed. He will address the importance of collaboration between the industry, government and academia, and he will touch upon issues such as conflict of interest and the taxpayer’s fair rate of return on the investment in research. There will be time for questions and discussion.""

"The lecture will take place on Friday, March 19, from 2:00 to 3:00 p.m. in Masur Auditorium in the Clinical Center (Building 10). It will also be webcast live at http://videocast.nih.gov.

Sign Language Interpreters will be provided. Individuals with disabilities who need reasonable accommodation to participate in this event should contact Kate Haessler at 301-348-1662, or the Federal Relay Service at 1-800-877-8339.

For more information, e-mail NCIDirectorslecture@matthewsgroup.com or visit the NCI Web site at http://cancer.gov/directorscorner"